The September formulary updates include the addition of 86 new National Drug Codes (NDCs), representing 46 different prescription drugs, many with multiple strengths.
The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).
Highlights of the September 2020 Formulary update include 13 newly-added generic drugs
The September Medicare Part D drug data includes 18 new generic medications, 13 of which are newly-introduced generic drugs. These new generic drugs include:
- CEFDINIR [Omnicef®],
- DEXABLISS [ZCORT®],
- DICLOFENAC EPOLAMINE [Licart®],
- METHYLPHENIDATE ER [Aptensio XR®],
- METHYLPHENIDATE ER [Metadate CD®],
- MICAFUNGIN [Mycamine®],
- NALOXONE [EVZIO®],
- NITISINONE [Orfadin®],
- NIZATIDINE [Axid®],
- POTASSIUM CL,
- TERIPARATIDE [Forteo®],
- VTOL LQ, and
- ZIPRASIDONE [Geodon®].
You can see our article "September 2020 Drug List Updates: Eighteen (18) new generic drugs added to many Medicare Part D plan formularies." found at on this site for more about coverage the new generics.
The September 2020 Formulary update includes sixteen (16) newly-added brand-name drugs
The September drug data updates also include twenty-eight (28) new brand-name drugs, sixteen (16) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
- ARAZLO®,
- Bynfezia®,
- DAYVIGO®,
- HELIDAC THERAPY®,
- ISTURISA®,
- LYUMJEV®,
- NEXLIZET®,
- ORIAHNN®,
- QINLOCK®,
- RELAFEN DS®,
- RETEVMO®,
- TABRECTA®,
- TUKYSA®,
- XCOPRI®,
- ZEMDRI®, and
- ZERVIATE®.
Reminders about Medicare prescription drug plan formulary changes
- Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.
- Your Medicare Part D plan
will notify you if the plan drops a medication you are currently using.
The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging. You can read more on this site
Summary of September 2020 NDC changes
There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 86 new September 2020 NDCs is as follows:
| Reason for NDC Addition | Occurrences |
| New Delivery Form | 7 |
| New Delivery Form and Strength | 4 |
| New Drug | 18 |
| New Drug and Strength | 37 |
| New Drug, Delivery Form and Strength | 1 |
| New Manufacturer | 9 |
| New Manufacturer and Strength | 6 |
| New Strength | 4 |
| Grand Total | 86 |
The following chart details the 86 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.
You can click on the Drug Code (NDC) or Drug Name below to go to our on this site Drug Finder ( on this site) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state). You can then change the state in our search form for details of drug coverage in your service area.
| NDC | Drug Name | Number of PDP Formularies* |
Number of MAPD Formularies* |
Notes |
| 00187209845 | ARAZLO 0.045% LOTION | 0 | 6 | New Drug |
| 62756045236 | BYNFEZIA 2,500 MCG/ML PEN INJECTOR | 3 | 67 | New Drug |
| 00781607861 | CEFDINIR 250 MG/5 ML ORAL SUSPENSION [Omnicef] | 69 | 391 | New Drug |
| 00007338313 | COREG CR 10 MG CAPSULE CPMP 24HR | 6 | 7 | New Strength |
| 62856041030 | DAYVIGO 10 MG TABLET | 0 | 9 | New Drug and Strength |
| 62856040530 | DAYVIGO 5 MG TABLET | 0 | 9 | New Drug and Strength |
| 00093351656 | DEFERASIROX 180 MG TABLET [Jadenu] | 51 | 333 | New Manufacturer and Strength |
| 71905040011 | DEXABLISS 11 DAY 1.5 MG TABLET DS PK [ZCORT] | 1 | 9 | New Drug |
| 59762070702 | DICLOFENAC EPOLAMINE 1.3% PATCH TD12 [Licart] | 2 | 114 | New Manufacturer and Strength |
| 70569015230 | DVORAH 325-30-16 MG TABLET [Panlor] | 0 | 7 | New Drug |
| 58406001004 | ENBREL 25 MG/0.5 ML SYRINGE | 64 | 390 | New Delivery Form |
| 58406004404 | ENBREL 50 MG/ML MINI CARTRIDGE | 60 | 382 | New Delivery Form |
| 58406002104 | ENBREL 50 MG/ML SYRINGE | 62 | 390 | New Delivery Form |
| 60793013230 | FLECTOR 1.3% PATCH TD12 | 2 | 67 | New Drug |
| 72065012012 | GVOKE HYPOPEN 2PK 0.5MG/0.1 ML AUTO INJECTOR | 43 | 272 | New Delivery Form |
| 72065012112 | GVOKE HYPOPEN 2-PK 1 MG/0.2 ML AUTO INJECTOR | 43 | 275 | New Delivery Form |
| 61958180501 | HARVONI 33.75-150 MG PELLET PACKET | 62 | 228 | New Delivery Form and Strength |
| 61958180401 | HARVONI 45-200 MG PELLET PACKET | 62 | 227 | New Delivery Form and Strength |
| 70199002114 | HELIDAC THERAPY PACK COMBO PKG | 0 | 10 | New Drug |
| 55292032060 | ISTURISA 1 MG TABLET | 8 | 82 | New Drug and Strength |
| 55292032260 | ISTURISA 10 MG TABLET | 8 | 82 | New Drug and Strength |
| 55292032160 | ISTURISA 5 MG TABLET | 8 | 82 | New Drug and Strength |
| 59148007928 | JYNARQUE 15 MG-15 MG TABLET SEQ | 9 | 170 | New Strength |
| 59148008028 | JYNARQUE 30 MG-15 MG TABLET SEQ | 9 | 170 | New Strength |
| 00024592001 | KEVZARA 150 MG/1.14 ML PEN INJECTOR | 9 | 142 | New Delivery Form |
| 00024592201 | KEVZARA 200 MG/1.14 ML PEN INJECTOR | 9 | 142 | New Delivery Form |
| 00002820705 | LYUMJEV 100 UNIT/ML KWIKPEN INSULN PEN | 1 | 29 | New Drug and Strength |
| 00002772801 | LYUMJEV 100 UNIT/ML VIAL | 1 | 29 | New Drug, Delivery Form and Strength |
| 00002822827 | LYUMJEV 200 UNIT/ML KWIKPEN INSULN PEN | 1 | 29 | New Drug and Strength |
| 53097057060 | MARINOL 10 MG CAPSULE | 0 | 4 | New Drug and Strength |
| 53097056860 | MARINOL 2.5 MG CAPSULE | 0 | 4 | New Drug and Strength |
| 53097056960 | MARINOL 5 MG CAPSULE | 0 | 4 | New Drug and Strength |
| 42858007645 | METHYLPHENIDATE ER 15 MG CAPSULE CSBP 40-60 [Aptensio XR] | 1 | 35 | New Manufacturer |
| 42858008045 | METHYLPHENIDATE ER 50 MG CAPSULE CSBP 40-60 [Metadate CD] | 1 | 35 | New Manufacturer |
| 42858007545 | METHYLPHENIDATE ER 10 MG CAPSULE CSBP 40-60 [Ritalin LA] | 1 | 35 | New Manufacturer |
| 42858007745 | METHYLPHENIDATE ER 20 MG CAPSULE CSBP 40-60 [Ritalin LA] | 1 | 34 | New Manufacturer |
| 42858007845 | METHYLPHENIDATE ER 30 MG CAPSULE CSBP 40-60 [Ritalin LA] | 1 | 34 | New Manufacturer |
| 42858007945 | METHYLPHENIDATE ER 40 MG CAPSULE CSBP 40-60 [Ritalin LA] | 1 | 34 | New Manufacturer |
| 42858008145 | METHYLPHENIDATE ER 60 MG CAPSULE CSBP 40-60 [Ritalin LA] | 1 | 35 | New Manufacturer |
| 51862061001 | METHYLPHENIDATE LA 20 MG CAPSULE CPBP 50-50 [Ritalin LA] | 9 | 187 | New Manufacturer |
| 51862061101 | METHYLPHENIDATE LA 30 MG CAPSULE CPBP 50-50 [Ritalin LA] | 9 | 186 | New Manufacturer |
| 63323072910 | MICAFUNGIN 100 MG VIAL [Mycamine] | 46 | 303 | New Drug and Strength |
| 63323072810 | MICAFUNGIN 50 MG VIAL [Mycamine] | 46 | 301 | New Drug and Strength |
| 72853005102 | NALOXONE 2 MG AUTO-INJECTOR[EVZIO] | 2 | 18 | New Drug |
| 72426081803 | NEXLIZET 180-10 MG TABLET | 1 | 37 | New Drug |
| 00254302202 | NITISINONE 10 MG CAPSULE [Orfadin] | 68 | 368 | New Drug and Strength |
| 00254302002 | NITISINONE 2 MG CAPSULE [Orfadin] | 68 | 368 | New Drug and Strength |
| 00254302102 | NITISINONE 5 MG CAPSULE [Orfadin] | 68 | 368 | New Drug and Strength |
| 00591313760 | NIZATIDINE 150 MG CAPSULE [Axid] | 47 | 334 | New Drug and Strength |
| 00591313830 | NIZATIDINE 300 MG CAPSULE [Axid] | 47 | 335 | New Drug and Strength |
| 24338026012 | NYMALIZE 60 MG/10 ML ORAL SYRINGE | 24 | 123 | New Drug |
| 00074101756 | ORIAHNN 300-1-0.5MG/300MG CAPSULE SEQ | 3 | 25 | New Drug |
| 68025007462 | OSMOLEX ER 322 MG DAILY DOSE TABLET BP 24H | 0 | 47 | New Strength |
| 00990925739 | POTASSIUM CL 20 MEQ-0.45% NACL IV SOLN | 63 | 359 | New Manufacturer and Strength |
| 00338070348 | POTASSIUM CL 40 MEQ/100 ML SOL PIGGYBACK | 42 | 286 | New Manufacturer and Strength |
| 73207010130 | QINLOCK 50 MG TABLET | 69 | 383 | New Drug |
| 50228042460 | RANOLAZINE ER 1,000 MG TABLET 12H [Ranexa] | 69 | 390 | New Manufacturer and Strength |
| 50228042360 | RANOLAZINE ER 500 MG TABLET 12H [Ranexa] | 69 | 390 | New Manufacturer and Strength |
| 15370017060 | RELAFEN DS 1,000 MG TABLET | 0 | 4 | New Drug |
| 00002397760 | RETEVMO 40 MG CAPSULE | 69 | 392 | New Drug and Strength |
| 00002298026 | RETEVMO 80 MG CAPSULE | 69 | 392 | New Drug and Strength |
| 61958150401 | SOVALDI 150 MG PELLET PACKET | 19 | 100 | New Delivery Form and Strength |
| 61958150501 | SOVALDI 200 MG PELLET PACKET | 19 | 99 | New Delivery Form and Strength |
| 00078070956 | TABRECTA 150 MG TABLET | 69 | 393 | New Drug and Strength |
| 00078071656 | TABRECTA 200 MG TABLET | 69 | 393 | New Drug and Strength |
| 47781065289 | TERIPARATIDE 620 MCG/2.48 ML PEN INJECTOR [Forteo] | 13 | 165 | New Drug |
| 51144000212 | TUKYSA 150 MG TABLET | 69 | 393 | New Drug and Strength |
| 51144000160 | TUKYSA 50 MG TABLET | 69 | 393 | New Drug and Strength |
| 16714065901 | VENLAFAXINE HCL 100 MG TABLET [Effexor] | 69 | 393 | New Drug and Strength |
| 57237017201 | VENLAFAXINE HCL 25 MG TABLET [Effexor] | 69 | 393 | New Drug and Strength |
| 57237017301 | VENLAFAXINE HCL 37.5 MG TABLET [Effexor] | 69 | 393 | New Drug and Strength |
| 57237017401 | VENLAFAXINE HCL 50 MG TABLET [Effexor] | 69 | 393 | New Drug and Strength |
| 57237017501 | VENLAFAXINE HCL 75 MG TABLET [Effexor] | 69 | 393 | New Drug and Strength |
| 70154011116 | VTOL LQ 50-325-40 MG/15 ML SOLUTION | 1 | 16 | New Drug |
| 71699010030 | XCOPRI 100 MG TABLET | 69 | 393 | New Drug and Strength |
| 71699020128 | XCOPRI 12.5-25 MG TITRATION PK TABLET DS PK | 69 | 391 | New Drug and Strength |
| 71699015030 | XCOPRI 150 MG TABLET | 69 | 393 | New Drug and Strength |
| 71699020328 | XCOPRI 150-200 MG TITRATION PK TABLET DS PK | 69 | 393 | New Drug and Strength |
| 71699020030 | XCOPRI 200 MG TABLET | 69 | 393 | New Drug and Strength |
| 71699010256 | XCOPRI 250 MG DAILY DOSE PACK TABLET | 69 | 392 | New Drug and Strength |
| 71699010356 | XCOPRI 350 MG DAILY DOSE PACK TABLET | 69 | 392 | New Drug and Strength |
| 71699005030 | XCOPRI 50 MG TABLET | 69 | 393 | New Drug and Strength |
| 71699020228 | XCOPRI 50-100 MG TITRATION PAK TABLET DS PK | 69 | 393 | New Drug and Strength |
| 69097082096 | ZEMDRI 500 MG/10 ML VIAL | 6 | 53 | New Drug |
| 71776002430 | ZERVIATE 0.24% EYE DROP DROPERETTE | 17 | 71 | New Drug |
| 43598084858 | ZIPRASIDONE 20 MG/ML VIAL [Geodon] | 69 | 387 | New Drug |
Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the on this site FormularyBrowser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at on this site.